Docking-based approach for identification of mutations that disrupt binding between Bcl-2 and Bax proteins: Inducing apoptosis in cancer cells.

Raghav, Pawan Kumar and Kumar, Rajesh and Kumar, Vinod and Raghava, Gajendra P S (2019) Docking-based approach for identification of mutations that disrupt binding between Bcl-2 and Bax proteins: Inducing apoptosis in cancer cells. Molecular genetics & genomic medicine, 7 (11). e910. ISSN 2324-9269

Full text not available from this repository. (Request a copy)
Official URL: https://onlinelibrary.wiley.com/doi/full/10.1002/m...

Abstract

Inducing apoptosis in cancer cells is an important step for the successful treatment of cancer patients. Bcl-2 is an antiapoptotic protein which determines apoptosis by interacting with proapoptotic members of the Bcl-2 family. Exome sequencing has identified Bcl-2 and Bax missense mutations in more than 40 cancer types. However, a little information is available about the functional impact of each Bcl-2 and Bax mutation on the pathogenesis of cancer.

Item Type: Article
Additional Information: Copyright of this article belongs to Wiley
Uncontrolled Keywords: Bax; Bcl-2; apoptosis; cancer; docking; mutation
Subjects: Q Science > QR Microbiology
Divisions: Faculty of Engineering, Science and Mathematics > School of Mathematics
Depositing User: Dr. K.P.S.Sengar
Date Deposited: 05 Dec 2019 14:03
Last Modified: 05 Dec 2019 14:03
URI: http://crdd.osdd.net/open/id/eprint/2488

Actions (login required)

View Item View Item